Abstract
Intraoperative heparin exposure and intra-/postoperative thrombocytopenia occur universally with cardiac surgery. Sometimes, heparin triggers formation of highly pathological platelet-activating antibodies that cause thrombocytopenia, hypercoagulability, and greatly increased risk of venous and/or arterial thrombosis beginning approximately 1 week post-surgery, a disorder called heparin-induced thrombocytopenia (HIT). The challenge is to distinguish HIT from the myriad of non-HIT thrombocytopenic disorders common to this patient population. The characteristic timing of HIT, and its hallmark of associated thrombosis, means that any otherwise unexplained platelet count fall of >40% (especially with associated thrombotic event) that begins during the characteristic day 5–10 “window” post-cardiac surgery should be presumed to be HIT unless proven otherwise. In contrast, early-onset and persisting thrombocytopenia following cardiac surgery is unlikely to be HIT. Growing recognition that HIT can begin or worsen after all heparin has been stopped (“autoimmune HIT”) indicates that this diagnosis should be considered even when thrombocytopenia or thrombosis is recognized up to 1 month following cardiac surgery.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsNotes
- 1.
Search details: Heparin-induced[All Fields] AND (“thrombocytopaenia”[All Fields] OR “thrombocytopenia”[MeSH Terms] OR “thrombocytopenia”[All Fields]) AND (“thoracic surgery”[MeSH Terms] OR (“thoracic”[All Fields] AND “surgery”[All Fields]) OR “thoracic surgery”[All Fields] OR (“cardiac”[All Fields] AND “surgery”[All Fields]) OR “cardiac surgery”[All Fields] OR “cardiac surgical procedures”[MeSH Terms] OR (“cardiac”[All Fields] AND “surgical”[All Fields] AND “procedures”[All Fields]) OR “cardiac surgical procedures”[All Fields] OR (“cardiac”[All Fields] AND “surgery”[All Fields])).
References
Warkentin TE, Greinacher A. Heparin-induced thrombocytopenia and cardiac surgery. Ann Thorac Surg. 2003;76(6):2121–31.
Warkentin TE, Greinacher A, Gruel Y, Aster RH, Chong BH, Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Laboratory testing for heparin-induced thrombocytopenia: a conceptual framework and implications for diagnosis. J Thromb Haemost. 2011;9(12):2498–500.
Warkentin TE. Heparin-induced thrombocytopenia, part 2: clinical course and treatment. J Crit Illn. 2005;20(2):36–43.
Warkentin TE. Heparin-induced thrombocytopenia in critically ill patients. Semin Thromb Hemost. 2015;41(1):49–60.
Warkentin TE, Sheppard JI. Clinical sample investigation (CSI) hematology: pinpointing the precise onset of heparin-induced thrombocytopenia (HIT). J Thromb Haemost. 2007;5(3):636–7.
Warkentin TE, Moore JC, Vogel S, Sheppard JI, Warkentin NI, Eikelboom JW. The serological profile of early-onset and persisting post-cardiac surgery thrombocytopenia complicated by “true” heparin-induced thrombocytopenia. Thromb Haemost. 2012;107(5):998–1000.
Warkentin TE. Clinical picture of heparin-induced thrombocytopenia. In: Warkentin TE, Greinacher A, editors. Heparin-induced thrombocytopenia. 5th ed. Boca Raton: CRC Press; 2013. p. 24–76.
Warkentin TE, Sheppard JI, Moore JC, Cook RJ, Kelton JG. Studies of the immune response in heparin-induced thrombocytopenia. Blood. 2009;113(20):4963–9.
Warkentin TE, Kelton JG. Temporal aspects of heparin-induced thrombocytopenia. N Engl J Med. 2001;344(17):1286–92.
Shih AW, Sheppard JI, Warkentin TE. Platelet count recovery and seroreversion in immune HIT despite continuation of heparin: further observations and literature review. Thromb Haemost. 2017;117(10):1868–74.
Kopolovic I, Warkentin TE. Progressive thrombocytopenia after cardiac surgery in a 67-year-old man. CMAJ. 2014;186(12):929–33.
Warkentin TE, Kelton JG. Delayed-onset heparin-induced thrombocytopenia and thrombosis. Ann Intern Med. 2001;135(7):502–6.
Levine RL, Hursting MJ, Drexler A, Lewis BE, Francis JL. Heparin-induced thrombocytopenia in the emergency department. Ann Emerg Med. 2004;44(5):511–5.
Jackson MR, Neilson WJ, Lary M, Baay P, Web K, Clagett GP. Delayed-onset heparin-induced thrombocytopenia and thrombosis after intraoperative heparin anticoagulation. Four case reports. Vasc Endovasc Surg. 2006;40(1):67–70.
Greinacher A, Selleng K, Warkentin TE. Autoimmune heparin-induced thrombocytopenia. J Thromb Haemost. 2017;15(11):2099–114.
Nguyen TH, Medvedev N, Delcea M, Greinacher A. Anti-platelet factor 4/polyanion antibodies mediate a new mechanism of autoimmunity. Nat Commun. 2017;8:14945.
Khoury M, Pitsis A, Poumpouridou-Kioura H, Soufla G, Kanthou C, Matoula N, et al. Acute intraoperative heparin-induced thrombocytopenia (HIT) and thrombosis during coronary artery bypass grafting: two case reports providing evidence for the role of preoperative LMWH in triggering sensitization. Thromb Res. 2016;146:126–30.
Antoniou T, Stavridis G, Daganou M, Melissari E, Gatzonis S. Heparin-induced thrombocytopenia thrombosis after cardiac surgery. A case report. Acta Anaesthesiol Scand. 2000;44(8):991–3.
Saltman AE, Dzik WH, Levitsky S. Immediate vein graft thrombectomy for acute occlusion after coronary artery bypass grafting. Ann Thorac Surg. 1999;67(6):1775–6.
Warkentin TE. Acute intraoperative HIT during heart surgery: why so rare? Thromb Res. 2016;146:110–2.
Zucker MJ, Sabnani I, Baran DA, Balasubramanian S, Camacho M. Cardiac transplantation and/or mechanical circulatory support device placement using heparin anti-coagulation in the presence of acute heparin-induced thrombocytopenia. J Heart Lung Transplant. 2010;29(1):53–60.
Warkentin TE, Pai M, Linkins LA. Direct oral anticoagulants for treatment of HIT: update of Hamilton experience and literature review. Blood. 2017;130(9):1104–13.
Warkentin TE. Heparin-induced thrombocytopenia and the anesthesiologist. Can J Anesth. 2002;49(6; Suppl):S36–49.
Pouplard C, May MA, Iochmann S, Amiral J, Vissac AM, Marchand M, et al. Antibodies to platelet factor 4-heparin after cardiopulmonary bypass in patients anticoagulation with unfractionated heparin or a low-molecular-weight heparin. Clinical implications for heparin-induced thrombocytopenia. Circulation. 1999;99(19):2530–6.
Warkentin TE, Sheppard JI, Horsewood P, Simpson PJ, Moore JC, Kelton JG. Impact of the patient population on the risk for heparin-induced thrombocytopenia. Blood. 2000;96(5):1703–8.
Pouplard C, May MA, Regina S, Marchand M, Fusciardi J, Gruel Y. Changes in platelet count after cardiac surgery can effectively predict the development of pathogenic heparin-dependent antibodies. Br J Haematol. 2005;128(6):837–41.
Selleng S, Malowsky B, Strobel U, Wessel A, Ittermann T, Wollert HG, et al. Early-onset and persisting thrombocytopenia in post-cardiac surgery patients is rarely due to heparin-induced thrombocytopenia even when antibody tests are positive. J Thromb Haemost. 2010;8(1):30–6.
Lillo-Le Louët A, Boutouyrie P, Alhenc-Gelas M, et al. Diagnostic score for heparin-induced thrombocytopenia after cardiopulmonary bypass. J Thromb Haemost. 2004;2(11):1882–8.
Selleng S, Selleng K, Wollert HG, Muellejans B, Lietz T, Warkentin TE, et al. Heparin-induced thrombocytopenia in patients requiring prolonged intensive care unit treatment after cardiopulmonary bypass. J Thromb Haemost. 2008;6:428–35.
Warkentin TE, Roberts RS, Hirsh J, Kelton JG. An improved definition of immune heparin-induced thrombocytopenia in postoperative orthopedic patients. Arch Intern Med. 2003;163(20):2518–24.
Warkentin TE. HITlights: a career perspective on heparin-induced thrombocytopenia. Am J Hematol. 2012;87(Suppl. 1):S92–9.
Kuitunen A, Suojaranta-Ylinen R, Raivio P, Kukkonen S, Lassila R. Heparin-induced thrombocytopenia following cardiac surgery is associated with poor outcome. J Cardiothorac Vasc Anesth. 2007;21(1):18–22.
Warkentin TE. Ischemic limb gangrene with pulses. N Engl J Med. 2015;373(7):642–55.
Josa M, Siouffi SY, Silverman AB, Barsamian EM, Khuri SF, Sharma GV. Pulmonary embolism after heart surgery. J Am Coll Cardiol. 1993;21(4):990–6.
Liu JC, Lewis BE, Steen LH, Grassman ED, Bakhos M, Blakeman B, et al. Patency of coronary artery bypass grafts in patients with heparin-induced thrombocytopenia. Am J Cardiol. 2002;89(8):979–81.
Warkentin TE, Sheppard JI, Sun JCJ, Jung H, Eikelboom JW. Anti-PF4/heparin antibodies and venous graft occlusion in postcoronary artery bypass surgery patients randomized to postoperative unfractionated heparin or fondaparinux thromboprophylaxis. J Thromb Haemost. 2013;11(2):253–60.
Gluckman TJ, Segal JB, Schulman SP, et al. Effect of anti-platelet factor-4/heparin antibody induction on early saphenous vein graft occlusion after coronary artery bypass surgery. J Thromb Haemost. 2009;7(9):1457–64.
Welsby IJ, Krakow EF, Heit JA, et al. The association of anti-platelet factor 4/heparin antibodies with early and delayed thromboembolism after cardiac surgery. J Thromb Haemost. 2016;15(1):57–65.
Bakaeen FG, Walkes JC, Reardon MJ. Heparin-induced thrombocytopenia associated with bilateral adrenal hemorrhage after coronary artery bypass surgery. Ann Thorac Surg. 2005;79(4):1388–90.
Hong AP, Cook DJ, Sigouin CS, Warkentin TE. Central venous catheters and upper-extremity deep-vein thrombosis complicating immune heparin-induced thrombocytopenia. Blood. 2003;101(8):3049–51.
Teh CH, Robertson MN, Warkentin TE, Henriksen PA, Brackenbury ET, Anderson JAM. Transient global amnesia as the presenting feature of heparin-induced thrombocytopenia. J Card Surg. 2010;25(3):300–2.
Warkentin TE, Greinacher A. Heparin-induced anaphylactic and anaphylactoid reactions: two distinct but overlapping syndromes. Expert Opin Drug Saf. 2009;8(2):129–44.
Thielmann M, Bunschkowski M, Tossios P, Selleng S, Marggraf G, Greinacher A, et al. Perioperative thrombocytopenia in cardiac surgical patients – incidence of heparin-induced thrombocytopenia, morbidities and mortality. Eur J Cardiothorac Surg. 2010;37(6):1391–5.
Bakchoul T, Jouni R, Warkentin TE. Protamine (heparin)-induced thrombocytopenia: a review of the serological and clinical features associated with anti-protamine/heparin antibodies. J Thromb Haemost. 2016;14(9):1685–95.
Saltzman DJ, Chang JC, Jimenez JC, Carson JG, Abolhoda A, Newman RS, Milliken JC. Postoperative thrombotic thrombocytopenic purpura after open heart operations. Ann Thorac Surg. 2010;89(1):119–23.
Jubelirer SJ, Ratliff HL, Cotes DJ, Riley MA, Welch CA. Thrombotic thrombocytopenic purpura (TTP) following coronary artery bypass: case series and review of the literature. W V Med J. 2015;111(1):10–4.
Warkentin TE, Anderson JAM. DITP causation: 3 methods better than 1? Blood. 2010;116(12):2002–3.
Warkentin TE. Drug-induced immune-mediated thrombocytopenia—from purpura to thrombosis. N Engl J Med. 2007;356(9):891–3.
Lubenow N, Eichler P, Albrecht D, Carlsson LE, Kothmann J, Rossocha WR, Hahn M, Quitmann H, Greinacher A. Very low platelet counts in post-transfusion purpura falsely diagnosed as heparin-induced thrombocytopenia. Report of four cases and review of literature. Thromb Res. 2000;100(3):115–25.
Warkentin TE, Levine MN, Hirsh J, Horsewood P, Roberts RS, Gent M, Kelton JG. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med. 1995;332(20):1330–5.
Warkentin TE, Sheppard JI, Heels-Ansdell D, Marshall JC, McIntyre L, Rocha MG, et al. Heparin-induced thrombocytopenia in medical surgical critical illness. Chest. 2013;144(3):848–58.
Piednoir P, Allou N, Provenchère S, Berroeta C, Huise MG, Philip I, et al. Heparin-induced thrombocytopenia after cardiac surgery: an observational study of 1,722 patients. J Cardiothorac Vasc Anesth. 2012;26(4):585–90.
Bucci C, Geerts WH, Sinclair A, Fremes SE. Comparison of the effectiveness and safety of low-molecular-weight heparin versus unfractionated heparin anticoagulation after heart valve surgery. Am J Cardiol. 2011;107(4):591–4.
Warkentin TE, Sheppard JI, Sigouin CS, Kohlmann T, Eichler P, Greinacher A. Gender imbalance and risk factor interactions in heparin-induced thrombocytopenia. Blood. 2006;108(9):2937–41.
Warkentin TE, Linkins LA. Non-necrotizing heparin-induced skin lesions and the 4T’s score. J Thromb Haemost. 2010;8(7):1483–5.
Warkentin TE, Greinacher A, Koster A, Lincoff AM. Treatment and prevention of heparin-induced thrombocytopenia. American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest. 2008;133(6 Suppl):340S–80S.
Linkins LA, Dans AL, Moores LK, et al. Treatment and prevention of heparin-induced thrombocytopenia: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141(2 Suppl):e495S–530S.
Warkentin TE, Sheppard JI, Moore JC, Sigouin CS, Kelton JG. Quantitative interpretation of optical density measurements using PF4-dependent enzyme-immunoassays. J Thromb Haemost. 2008;6(8):1304–12.
Warkentin TE, Arnold DM, Nazi I, Kelton JG. The platelet serotonin-release assay. Am J Hematol. 2015;90(6):564–72.
Warkentin TE, Sheppard JI, Linkins LA, Arnold DM, Nazy I. Performance characteristics of an automated latex immunoturbidimetric assay [HemosIL® HIT-Ab(PF4-H)] for the diagnosis of immune heparin-induced thrombocytopenia. Thromb Res. 2017;153:108–17.
Warkentin TE, Pai M, Sheppard JI, Schulman S, Spyropoulos AC, Eikelboom JW. Fondaparinux treatment of acute heparin-induced thrombocytopenia confirmed by the serotonin-release assay: a 30-month, 16-patient case series. J Thromb Haemost. 2011;9(12):2389–96.
Warkentin TE. Anticoagulant failure in coagulopathic patients: PTT confounding and other pitfalls. Exp Opin Drug Saf. 2014;13(1):25–43.
Warkentin TE, Davidson BL, Büller HR, Gallus A, Gent M, Lensing AWA, et al. Prevalence and risk of preexisting heparin-induced thrombocytopenia antibodies in patients with acute VTE. Chest. 2011;140(2):366–73.
Warkentin TE, Sheppard JI. Serological investigation of patients with a previous history of heparin-induced thrombocytopenia who are reexposed to heparin. Blood. 2014;123(16):2485–93.
Warkentin TE, Anderson JAM. How I treat patients with a history of heparin-induced thrombocytopenia. Blood. 2016;128(3):348–59.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Warkentin, T.E. (2019). If the Platelets Are Low, Is It HIT?. In: Lonchyna, V. (eds) Difficult Decisions in Cardiothoracic Critical Care Surgery. Difficult Decisions in Surgery: An Evidence-Based Approach. Springer, Cham. https://doi.org/10.1007/978-3-030-04146-5_32
Download citation
DOI: https://doi.org/10.1007/978-3-030-04146-5_32
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-04145-8
Online ISBN: 978-3-030-04146-5
eBook Packages: MedicineMedicine (R0)